Garden State Investment Advisory Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-50
Closed -$1.27K 331
2025
Q1
$1.27K Sell
50
-4,950
-99% -$130K ﹤0.01% 270
2024
Q4
$61.5K Buy
5,000
+4,950
+9,900% +$134K 0.02% 264
2024
Q3
$1.45K Sell
50
-50
-50% -$1.46K ﹤0.01% 244
2024
Q2
$2.8K Hold
100
﹤0.01% 234
2024
Q1
$2.77K Buy
+100
New +$2.77K ﹤0.01% 226

Other funds holding PFE

Garden State Investment Advisory Services's PFE Position: Q2 2026 in Review

Garden State Investment Advisory Services increased its Pfizer (PFE) stake by 6% in Q2 2026, buying an estimated $30.3K and bringing the position to 20,511 shares worth $494K. The position accounts for 0.09% of the portfolio, ranked #177.

Garden State Investment Advisory Services first reported a position in PFE in Q4 2022 and has held it in 15 quarters since. The position peaked at $718K in Q2 2025. 2,239 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Garden State Investment Advisory Services held 20,511 shares of Pfizer worth $494K as of Q2 2026.
  • Garden State Investment Advisory Services bought 1,158 Pfizer shares in Q2 2026, an estimated $30.3K.
  • Pfizer made up 0.09% of Garden State Investment Advisory Services's portfolio in Q2 2026, its #177 holding.
  • Garden State Investment Advisory Services first reported a position in Pfizer in Q4 2022 and has held it in 15 quarters since.
  • Garden State Investment Advisory Services's Pfizer position peaked at $718K in Q2 2025.
  • 2,239 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Garden State Investment Advisory Services's 13F filing for Q2 2026, filed 11 Aug 2026.